Treatment of ADA2 deficiency involves anti-tumor necrosis factor alpha agents, which prevent and eliminate manifestations of autoinflammatory disease, reduce the risk of ischemic stroke, and relieve immunodeficiency.5 Here, ADA2 is linked to ischemic stroke.